EP2694106
Aðferðir til að auka skilvirkni krabbameinsmeðferðar með FOLR1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2012EP published:
13.12.2017EP application number:
12764885.5
EP translation filed:
27.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
29.3.2032Expiry date:
29.3.2027Next due date:
31.3.2027
Title:
METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY
Timeline
Today
30.3.2012EP application
13.12.2017EP Publication
27.2.2018Translation submitted
15.3.2018Registration published
29.3.2027Expires
Owner
Name:
ImmunoGen, Inc.Address:
830 Winter Street, 02451, Waltham, MA, US
Inventor
Name:
CARRIGAN, Christina, N.Address:
San Francisco, CA, US
Name:
WHITEMAN, Kathleen, R.Address:
Wilmington, MA, US
Name:
PAYNE, GillianAddress:
Waban, MA, US
Name:
LADD, SharronAddress:
Gregory, MI, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161471007 PDate:
1.4.2011Country:
US
Classification
Categories:
A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.4.2018
Expires: 29.3.2019
Payer: Árnason Faktor
Number: 8
Paid: 4.3.2019
Expires: 29.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 3.3.2020
Expires: 29.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.3.2021
Expires: 29.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 2.3.2022
Expires: 29.3.2023
Payer: Patice ehf.
Number: 12
Paid: 9.3.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.3.2024
Expires: 29.3.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 29.1.2025
Expires: 29.3.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.3.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.